Canopy Growth Corporation
CANNABINOID DERIVATIVES

Abstract:

This disclosure relates to a cannabinoid derivative of formula (I), pharmaceutical composition thereof, and method of treating or preventing diseases associated with cannabinoid receptor in a subject in need thereof, wherein the cannabinoid receptor is one or more of CB1, CB2, 5HT1A, 5HT2A, GPR18, GPR55, GPR119, TRPV1, TRPV2, PPAR.gamma. or a .mu.-opioid receptor.